18.96
price up icon1.94%   0.36
after-market アフターアワーズ: 19.06 0.10 +0.53%
loading
前日終値:
$18.60
開ける:
$18.55
24時間の取引高:
951.32K
Relative Volume:
1.18
時価総額:
$1.66B
収益:
$23.38M
当期純損益:
$-155.22M
株価収益率:
-8.6575
EPS:
-2.19
ネットキャッシュフロー:
$-134.36M
1週間 パフォーマンス:
-0.58%
1か月 パフォーマンス:
-8.67%
6か月 パフォーマンス:
-49.39%
1年 パフォーマンス:
-58.52%
1日の値動き範囲:
Value
$18.49
$19.59
1週間の範囲:
Value
$16.95
$19.67
52週間の値動き範囲:
Value
$16.95
$46.40

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
名前
Ideaya Biosciences Inc
Name
セクター
Healthcare (1169)
Name
電話
650-443-6209
Name
住所
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
職員
131
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
IDYA's Discussions on Twitter

IDYA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IDYA
Ideaya Biosciences Inc
18.96 1.66B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 開始されました Stephens Overweight
2024-11-05 ダウングレード Leerink Partners Outperform → Market Perform
2024-10-24 開始されました UBS Buy
2024-10-15 開始されました Cantor Fitzgerald Overweight
2024-07-08 開始されました Mizuho Outperform
2024-03-08 開始されました BTIG Research Buy
2023-08-08 開始されました SVB Securities Outperform
2023-05-24 開始されました Goldman Buy
2023-04-24 アップグレード Stifel Hold → Buy
2023-03-23 開始されました Berenberg Buy
2023-02-28 開始されました RBC Capital Mkts Outperform
2022-12-28 開始されました CapitalOne Overweight
2022-10-27 開始されました Citigroup Buy
2022-08-15 ダウングレード Stifel Buy → Hold
2022-07-18 再開されました Oppenheimer Outperform
2022-03-10 アップグレード Stifel Hold → Buy
2021-09-23 開始されました Stifel Hold
2021-06-04 再開されました Robert W. Baird Outperform
2021-03-11 開始されました Guggenheim Buy
2020-10-07 開始されました Wedbush Outperform
2020-09-01 開始されました Northland Capital Outperform
2020-07-13 アップグレード JP Morgan Neutral → Overweight
2020-06-17 繰り返されました H.C. Wainwright Buy
2020-04-06 開始されました H.C. Wainwright Buy
2020-03-13 開始されました ROTH Capital Buy
2019-10-17 開始されました Oppenheimer Outperform
2019-09-10 開始されました Robert W. Baird Outperform
2019-06-17 開始されました Citigroup Buy
2019-06-17 開始されました JP Morgan Neutral
2019-06-17 開始されました Jefferies Buy
すべてを表示

Ideaya Biosciences Inc (IDYA) 最新ニュース

pulisher
Mar 11, 2025

Ideaya Biosciences stock hits 52-week low at $17.28 By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Ideaya Biosciences stock hits 52-week low at $17.28 - Investing.com

Mar 11, 2025
pulisher
Mar 10, 2025

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GuruFocus.com

Mar 10, 2025
pulisher
Mar 09, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up – What’s Next? - Defense World

Mar 09, 2025
pulisher
Mar 05, 2025

IDEAYA Announces Further Gilead Sciences Clinical Study Collabor - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

IDEAYA Biosciences, Inc. (IDYA) Partners with ATTMOS for AI-Driven Drug Discovery Platform - Insider Monkey

Mar 05, 2025
pulisher
Mar 04, 2025

Top 10 AI Trending News on Wall Street - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

IDEAYA Biosciences Partners With ATTMOS To Advance AI/ML-Driven Oncology Drug Discovery - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accele - GuruFocus.com

Mar 03, 2025
pulisher
Mar 03, 2025

Ideaya Biosciences stock hits 52-week low at $19.95 - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Ideaya Biosciences stock hits 52-week low at $19.95 By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

IDEAYA Biosciences, ATTMOS Collaborate to Advance Small Molecule Discovery for Undruggable Oncology Targets - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Can AI Finally Crack "Undruggable" Cancer Targets? IDEAYA's New Tech Partnership Aims to Revolutionize Oncology - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets - PR Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Rhumbline Advisers Has $2.92 Million Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Rule 5635(c)(4) - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

IDEAYA Biosciences Grants Stock Options to 4 New Employees Under Inducement Plan - StockTitan

Feb 28, 2025
pulisher
Feb 28, 2025

When the Price of (IDYA) Talks, People Listen - Stock Traders Daily

Feb 28, 2025
pulisher
Feb 24, 2025

Fair Value analysis proves accurate as IDEAYA shares drop 41% in 10 months - Investing.com India

Feb 24, 2025
pulisher
Feb 19, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month LowWhat's Next? - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Issues Quarterly Earnings Results, Misses Expectations By $0.82 EPS - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month Low – Here’s Why - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

IDEAYA Biosciences, Inc. SEC 10-K Report - TradingView

Feb 18, 2025
pulisher
Feb 18, 2025

Fiera Capital Corp Has $30.44 Million Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

IDEAYA Biosciences' SWOT analysis: cancer therapy stock poised for pivotal year - Investing.com

Feb 17, 2025
pulisher
Feb 17, 2025

How To Trade (IDYA) - Stock Traders Daily

Feb 17, 2025
pulisher
Feb 17, 2025

IDEAYA announces proposed public offering of common stock and pre-funded warrants - MSN

Feb 17, 2025
pulisher
Feb 16, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Trading Down 4.8%Time to Sell? - MarketBeat

Feb 16, 2025
pulisher
Feb 15, 2025

IDEAYA Biosciences Stock Gains Momentum as Analysts Reaffirm Bullish Outlook - HPBL

Feb 15, 2025
pulisher
Feb 15, 2025

IDEAYA Biosciences' (IDYA) "Overweight" Rating Reiterated at Stephens - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Down -8.63% in 4 Weeks, Here's Why You Should You Buy the Dip in IDEAYA Biosciences (IDYA) - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

IDEAYA Biosciences (IDYA) Expected to Announce Earnings on Tuesday - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

IDEAYA Biosciences Reports 2024 Financials and Business Update - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

WCM Investment Management LLC Buys Shares of 241,894 IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Ideaya Biosciences stock hits 52-week low at $21.02 By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 13, 2025

Q1 Earnings Estimate for IDYA Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA BIOSCIENCES Earnings Results: $IDYA Reports Quarterly Earnings - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Ideaya Biosciences falls as quarterly loss widens - TradingView

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA announces expanded collaboration with Gilead Sciences - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Ideaya Biosciences enters additional supply pact with Gilead for IDE397 - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule - Fierce Biotech

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA Biosciences Q4 Loss Widens, Revenue Rises -February 13, 2025 at 06:59 am EST - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q4 Collaboration Revenue of $7M - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA Q4 Earnings: Massive $1.1B War Chest Fuels Breakthrough Cancer Drug Development - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy® and IDE397 in MTAP-Deletion NSCLC - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Ideaya Biosciences stock hits 52-week low at $21.02 - MSN

Feb 13, 2025

Ideaya Biosciences Inc (IDYA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
大文字化:     |  ボリューム (24 時間):